Axonics Future Growth
Future criteria checks 4/6
Axonics is forecast to grow earnings and revenue by 55.1% and 16.5% per annum respectively. EPS is expected to grow by 55.6% per annum. Return on equity is forecast to be 5.7% in 3 years.
Key information
55.1%
Earnings growth rate
55.6%
EPS growth rate
Medical Equipment earnings growth | 17.1% |
Revenue growth rate | 16.5% |
Future return on equity | 5.7% |
Analyst coverage | Good |
Last updated | 12 Nov 2024 |
Recent future growth updates
Recent updates
Axonics' Market Growth Strengthens Boston Scientific's Future
Nov 05A Look At The Fair Value Of Axonics, Inc. (NASDAQ:AXNX)
Jul 14Axonics, Inc.'s (NASDAQ:AXNX) Earnings Haven't Escaped The Attention Of Investors
Jun 20Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 21% Discount?
Mar 27Here's Why We're Not At All Concerned With Axonics' (NASDAQ:AXNX) Cash Burn Situation
Feb 28Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 32% Discount?
Nov 28Axonics stock falls 5.6% after Needham downgrades rating
Oct 10Axonics Stock Is A Buy Amid Current Capex Cycle
Sep 07Axonics prices stock offering of 1.75M shares
Aug 03Companies Like Axonics (NASDAQ:AXNX) Can Afford To Invest In Growth
Aug 02Axonics: A Strong Medical Device Play With Significant Revenue Growth Opportunities
May 30Axonics (NASDAQ:AXNX) Is In A Strong Position To Grow Its Business
Apr 19Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 635 | 74 | N/A | N/A | 8 |
12/31/2025 | 540 | 47 | 65 | N/A | 10 |
12/31/2024 | 454 | -2 | 31 | N/A | 6 |
9/30/2024 | 432 | -6 | 5 | 14 | N/A |
6/30/2024 | 409 | -2 | 19 | 26 | N/A |
3/31/2024 | 387 | -16 | -16 | -10 | N/A |
12/31/2023 | 366 | -6 | -6 | -2 | N/A |
9/30/2023 | 343 | -12 | -1 | 2 | N/A |
6/30/2023 | 320 | -32 | -9 | -7 | N/A |
3/31/2023 | 296 | -46 | 9 | 12 | N/A |
12/31/2022 | 274 | -60 | 1 | 3 | N/A |
9/30/2022 | 241 | -76 | -16 | -13 | N/A |
6/30/2022 | 217 | -77 | -22 | -20 | N/A |
3/31/2022 | 194 | -80 | -33 | -31 | N/A |
12/31/2021 | 180 | -80 | -50 | -47 | N/A |
9/30/2021 | 162 | -76 | -71 | -69 | N/A |
6/30/2021 | 150 | -68 | -87 | -85 | N/A |
3/31/2021 | 120 | -63 | -88 | -86 | N/A |
12/31/2020 | 112 | -55 | -87 | -84 | N/A |
9/30/2020 | 87 | -66 | -86 | -84 | N/A |
6/30/2020 | 53 | -82 | -90 | -88 | N/A |
3/31/2020 | 39 | -81 | -95 | -94 | N/A |
12/31/2019 | 14 | -80 | -85 | -83 | N/A |
9/30/2019 | 4 | -67 | -66 | -65 | N/A |
6/30/2019 | 3 | -49 | -50 | -49 | N/A |
3/31/2019 | 2 | -39 | -39 | -38 | N/A |
12/31/2018 | 1 | -32 | -33 | -31 | N/A |
9/30/2018 | 0 | -28 | -29 | -27 | N/A |
6/30/2018 | 0 | -25 | N/A | -24 | N/A |
3/31/2018 | 0 | -20 | N/A | -21 | N/A |
12/31/2017 | 0 | -18 | N/A | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AXNX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: AXNX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AXNX is expected to become profitable in the next 3 years.
Revenue vs Market: AXNX's revenue (16.5% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: AXNX's revenue (16.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AXNX's Return on Equity is forecast to be low in 3 years time (5.7%).